Cypris Therapeutics is a pharmaceutical start-up that emphasizes the importance of synthetic chemistry in developing innovative therapies for unmet clinical needs. The company is based in Syracuse, NY, and was established through a collaboration between Ichor Life Sciences and Florida State University. This partnership provides Cypris with the intellectual and material resources necessary to transform their scientific ideas into clinically viable treatments. Their mission focuses on creating solutions for urgent health challenges, particularly targeting aggressive diseases such as brain, colon, and pancreatic cancers, which currently lack effective therapies.

The company's technology is rooted in the exploration of natural molecules, which serve as inspiration for their drug development efforts. By leveraging proprietary synthetic chemistry techniques, Cypris Therapeutics aims to enhance and refine these natural compounds, allowing for the creation of next-generation therapies. This approach not only highlights their commitment to addressing critical health issues but also underscores their innovative methodology in drug development, positioning them as a forward-thinking entity in the pharmaceutical landscape.

United States

Cypris Therapeutics is a chemistry-focused pharmaceutical start-up that uses proprietary synthetic chemistry and drug development skills to produce effective therapeutics. The company has launched as the newest Ichor Life Sciences portfolio company and has secured over $500k in pre-seed funding. As the company moves forward, it continues to seek additional funding and partnerships to support its ambitious goals.

Cypris Therapeutics

Company Details